
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex is well-positioned to benefit from the increasing demand for medical technology products that improve patient outcomes, reduce costs, and improve safety. Their strong presence in the Americas and growing presence in EMEA and Asia make them a global player in the market. The upcoming results of the BIOMAG-II trial and potential changes to the European Society of Cardiology guidelines could lead to increased sales for their innovative products, further driving growth and profitability.
Bears say
Teleflex is expected to see mid-single digit growth due to its Interventional business, however, its recent 2Q results have shown issues with this segment and overall revenue growth. Additionally, its cost reduction efforts may not be enough to offset these challenges and achieve the desired margin improvements and double-digit earnings growth. This, combined with its high reliance on the Americas for revenue, is concerning for the company's long-term viability.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares